Overview

Effects of Short-term Atorvastatin Treatment on Vaccination Efficacy in Nonresponder Persons to Hepatitis B Vaccine

Status:
Unknown status

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether short-term Atorvastatin can increase the immunity response to hepatitis B vaccination in vaccine Nonresponders.

Phase:

Phase 4

Details

Lead Sponsor:

Nematollah Jonaidi Jafari

Treatments:

Atorvastatin
Atorvastatin Calcium
Vaccines